Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis.
about
Update on advances in molecular PET in urological oncologyAdvances in bladder cancer imaging.Management of urological malignancies: Has positron emission tomography/computed tomography made a difference?Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.Appropriateness criteria of FDG PET/CT in oncology.PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.Detecting Metastatic Bladder Cancer Using (18)F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.PET/CT and MRI in Bladder Cancer.Molecular imaging of urogenital diseases.Nuclear medicine in urological cancers: what is new?Evolving role of positron emission tomography (PET) in urological malignancy.Preoperative imaging for staging bladder cancer.Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.Current Staging Procedures in Urinary Bladder CancerPreoperative Imaging for Clinical Staging Prior to Radical Cystectomy.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Advances in Imaging in Prostate and Bladder Cancer.Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.Comparing RECIST with EORTC criteria in metastatic bladder cancer.Detecting primary bladder cancer using delayed (18)F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography imaging after forced diuresis.[Functional imaging in bladder cancer].Diagnostic accuracy of C-11 choline and C-11 acetate for lymph node staging in patients with bladder cancer: a systematic review and meta-analysis.PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.[Radionuclide therapy and diagnostics in urology].[(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.18 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review
P2860
Q33625389-F3EBF2ED-35BC-475A-9A3A-4B9A01581378Q34662750-7E7678CF-72B1-4320-AC02-21D75207D991Q34990800-CC2B9098-3C3D-4448-961E-536A8A678C96Q35048726-4584270B-F6AE-4DF4-88CD-14DD1BED4847Q35568776-248C1249-4934-46B2-9438-778DBCE26614Q35776939-DCE692FC-19DD-4F8C-8F9F-39744D7AA910Q36187084-36402935-04BC-48FD-A9F9-EA79AB4C98E7Q36654987-2F80BA88-C5DC-485D-AB67-0D0371D85ACEQ37550399-CD10F87B-FD9A-491D-9C2E-130D2132E7D9Q38268168-D91B508C-43D2-4D7E-856D-0D4ABEC94AE6Q38269763-E57B74BA-B360-45A8-9644-9408E4D1DF7AQ38365924-9B700DB2-FBE2-44AC-A067-2D6C4477DE2CQ38391343-A457DD43-774A-45A0-B7EF-B9E9FE5D029DQ38715998-23B1F1E4-C9E9-4B74-9229-419F5717D947Q38901788-BA07D03A-29E8-4BD5-960C-334A87715B03Q39307896-63DACF29-D3E7-4BD7-B14C-66371F509D21Q39441078-EEC13373-C8EC-435D-91DB-699BA2939ADAQ39450381-6EC97880-493C-48F3-ABD2-0F5EDD0DADA8Q40076302-30C44465-736A-46CE-9044-68D2E8EEC5C6Q40699016-C6C880C6-DCA5-4A09-8A5E-89404AE3B489Q43066911-8AB17280-A2C9-4DC3-8672-BF0F7BF6484FQ45909222-0FB8B0D7-2270-4B5C-AC60-2958360494EFQ48320897-15C7079C-9C9C-4FC2-900A-82E96BCB4C0BQ49165684-3531236A-2D50-44D3-AB1B-502C36989464Q52997721-B1422EC5-40DD-44E0-BBA4-B75893136553Q53028971-66C95E67-FE2F-4692-A01C-596ADAB1EA6BQ53104789-8584FFCB-0E1B-4EBA-B252-C40824DA62ADQ53126609-D9D9F1A3-1D67-4E81-A216-F89224DC08A2Q59130946-4A80D442-3D95-4BA6-BA61-B57F629268E2
P2860
Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@en
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@nl
type
label
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@en
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@nl
prefLabel
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@en
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@nl
P2093
P1476
Clinical value of FDG PET or P ...... emic review and meta-analysis.
@en
P2093
Cheng-Chieh Lin
Chia-Hung Kao
Hsin-Yi Wang
Ji-An Liang
Jin-Hua Chen
Wan-Yu Lin
P304
P356
10.1016/J.EJRAD.2011.07.018
P577
2011-09-06T00:00:00Z